$1.38 +0.06 (4.55%)

Standard BioTools Inc. Common Stock (LAB)

Standard BioTools Inc. (LAB) is a provider of laboratory instruments, software, and consumables used in life science research and diagnostics. The company specializes in enabling scientific and clinical discoveries through its innovative solutions for genomics, proteomics, and cell analysis, supporting pharmaceutical, biotech, and academic research communities.

🚫 Standard BioTools Inc. Common Stock does not pay dividends

Company News

Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
GlobeNewswire Inc. • Marissa Bychir • July 21, 2025

Standard BioTools will report its second quarter 2025 financial results on August 11, 2025, hosting a conference call at 4:30 p.m. ET to discuss financial performance and operational progress.

5 Medical Info Systems Stock to Buy for a Stable Portfolio
Zacks Investment Research • Nalak Das • June 24, 2024

We have narrowed our search to five medical info systems stocks. These are: HIMS, ENOV, LUNG, PHR, LAB.

Quantum-Si And 2 Other Penny Stocks Insiders Are Buying
Benzinga • Avi Kapoor • March 7, 2024

The Dow Jones index closed higher by around 75 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable ins...

Best Penny Stocks This Week? 3 To Watch During Earnings Season
PennyStocks • J. Samuel • October 23, 2023

Best penny stocks to buy? Here are 3 to watch this week. The post Best Penny Stocks This Week? 3 To Watch During Earnings Season appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2022 Update
Seeking Alpha • John Vincent • June 6, 2022

Halvorsen's 13F portfolio value decreased from $34.49B to $24.74B this quarter. The top 3 positions are T-Mobile US, Amazon.com, and General Electric, together, at ~16% of the portfolio.